Standout Papers

Amyloid-Related Imaging Abnormalities in 2 Phase 3 Studies Evaluating Aducanumab in Patients With Early Alzheimer... 2021 2026 2022 2024383
  1. Amyloid-Related Imaging Abnormalities in 2 Phase 3 Studies Evaluating Aducanumab in Patients With Early Alzheimer Disease (2021)
    Stephen Salloway, Spyros Chalkias et al. JAMA Neurology
  2. Updated safety results from phase 3 lecanemab study in early Alzheimer’s disease (2024)
    Lawrence S. Honig, Marwan N. Sabbagh et al. Alzheimer s Research & Therapy

Immediate Impact

5 from Science/Nature 66 standout
Sub-graph 1 of 21

Citing Papers

Alzheimer’s Disease Detection Using Deep Learning on Neuroimaging: A Systematic Review
2024 Standout
Ultrasound Blood–Brain Barrier Opening and Aducanumab in Alzheimer’s Disease
2024 Standout
3 intermediate papers

Works of Derk D. Purcell being referenced

Detection and Management of Amyloid-Related Imaging Abnormalities in Patients with Alzheimer's Disease Treated with Anti-Amyloid Beta Therapy
2022
Amyloid-Related Imaging Abnormalities in 2 Phase 3 Studies Evaluating Aducanumab in Patients With Early Alzheimer Disease
2021 Standout
and 1 more

Author Peers

Author Last Decade Papers Cites
Derk D. Purcell 250 497 184 223 27 1.1k
Anders Rodell 289 340 211 150 46 1.3k
Mélissa Savard 138 827 214 575 49 1.2k
Kim Vang 245 396 209 86 23 1.2k
N. P. L. G. Verhoeff 204 408 215 512 38 1.3k
Serena Amici 168 324 144 374 26 991
Billy Dunn 176 420 179 357 21 1.2k
Mira Chamoun 147 843 205 641 58 1.2k
Clare L. Smith 172 701 139 653 23 1.1k
Emily S. Lundt 154 547 74 697 44 1.2k
Ken Kazama 234 543 189 150 19 1.1k

All Works

Loading papers...

Rankless by CCL
2026